Post-IPO Equity Medical Companies

Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

Monogram Orthopaedics is a producer of surgical robotic equipment.

SeaStar Medical is a commercial-stage medical device company that develops immunomodulating technologies.

ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development.

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Clever Leaves is a multi-national operator (MNO) and a licensed producer of pharmaceutical-grade medical cannabis.

Sharp Therapeutics is engaged in the development of biosensors for cellular biology research and high-throughput screening.

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Carvolix is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Alzinova operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.

Delta 9 Cannabis is a company with a large, expanding production facility licensed to produce and sell medical marijuana.